by John McMillan | Aug 23, 2024 | Health
Dan Baumgardt, University of BristolOne of my grandmother’s favourite things to cook was cold pressed ox tongue, though it’s a tradition that I don’t really feel the need to continue. Have you ever seen one? Not only is it colossal, but requires a lot of faff in...
by John McMillan | Aug 23, 2024 | COVID-19, Health
Sheena Cruickshank, University of Manchester This summer has seen a large COVID wave – one which is showing potential to be bigger than the 2023 winter wave was. The current wave has largely been driven by the so-called FLiRT variants, which have acquired greater...
by John McMillan | Aug 23, 2024 | Disease, Health, Virology
Rodney E. Rohde, Texas State University On Aug. 14, 2024, the World Health Organization declared mpox a public health emergency of international concern. There have been over 15,600 cases and over 530 deaths reported in the Democratic Republic of the Congo and...
by John McMillan | Aug 23, 2024 | Health
Justin Stebbing, Anglia Ruskin University Consuming too much caffeine is definitely bad for your health, and there may be good reasons why some people want to quit it altogether. But if you despair at the idea of giving up your morning coffee, fear not. There’s lots...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Nasia Safdar, University of Wisconsin-Madison A new study from the National Institutes of Health shows a jump in both hospital-acquired infections and resistance to the antibiotics used to treat them. The findings are based on data gathered at 120 U.S. hospitals from...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Tatiane Vilaca, University of Sheffield and Richard Eastell, University of Sheffield A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of...
Recent Comments